Gastric ulcers in foals represent erosions or lesions in the stomach lining that range from superficial mucosal damage to deep ulceration potentially penetrating through the stomach wall. Unlike adult horses where squamous ulcers in the non-glandular region predominate, foals commonly develop ulcers in both the glandular and squamous portions of the stomach, with glandular ulceration being particularly significant in neonates. The condition affects foals from birth through weaning, with different presentations, risk factors, and outcomes depending on age at onset. Gastric ulcers represent one of the most common gastrointestinal disorders in foals and a significant cause of morbidity in both hospitalized and farm-raised populations.
The prevalence of gastric ulcers in foals is substantial, with studies demonstrating ulceration in a high percentage of foals examined endoscopically. Virtually all foals develop some degree of gastric ulceration at some point during the first months of life, though many cases remain subclinical and resolve without specific treatment. Clinically significant ulceration occurs more commonly in foals experiencing stress, illness, or hospitalization. The condition affects foals of all breeds and management systems, though intensive management and early weaning practices may increase risk. Neonatal foals experiencing other health problems face particularly high risk for serious ulcer development.
The impact of gastric ulcers on foal health varies from insignificant subclinical lesions to life-threatening perforations. Mild ulceration may cause subtle signs including intermittent discomfort, reduced nursing, and slow growth. Moderate ulceration produces more obvious clinical signs including colic, bruxism, and failure to thrive. Severe ulceration, particularly in critically ill neonates, can result in perforation with peritonitis representing a surgical emergency with guarded prognosis. The association between gastric ulceration and other neonatal diseases creates a cycle where illness promotes ulcer development while ulceration contributes to ongoing morbidity.
Fortunately, gastric ulcers in foals are highly treatable when recognized and managed appropriately. Acid-suppressive therapy using proton pump inhibitors forms the cornerstone of treatment, with omeprazole being the most commonly employed medication. Mucosal protectants provide additional benefit for glandular ulceration. Management modifications that reduce stress and ensure appropriate feeding patterns support healing. Prevention strategies in at-risk populations can dramatically reduce ulcer incidence and severity. With appropriate attention to risk factors and early intervention when clinical signs develop, most foals with gastric ulcers respond well to treatment and recover without long-term consequences.
